140 related articles for article (PubMed ID: 8502664)
21. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
22. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corno C; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Endocrinol Invest; 2019 Aug; 42(8):951-965. PubMed ID: 30674010
[TBL] [Abstract][Full Text] [Related]
24. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
[TBL] [Abstract][Full Text] [Related]
25. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
Hacker AD
Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats.
Chao C; Madeddu P; Wang C; Liang Y; Chao L; Chao J
Am J Physiol; 1996 Jul; 271(1 Pt 2):F78-86. PubMed ID: 8760246
[TBL] [Abstract][Full Text] [Related]
27. Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension.
Cassis L; Shenoy U; Lipke D; Baughn J; Fettinger M; Gillespie M
Biochem Pharmacol; 1997 Jul; 54(1):27-31. PubMed ID: 9296348
[TBL] [Abstract][Full Text] [Related]
28. H
Feng S; Chen S; Yu W; Zhang D; Zhang C; Tang C; Du J; Jin H
Lab Invest; 2017 Mar; 97(3):268-278. PubMed ID: 27941756
[TBL] [Abstract][Full Text] [Related]
29. Tenascin synthesis, deposition, and isoforms in monocrotaline-induced pulmonary hypertensive rat lungs.
Lipke DL; Aziz SM; Fagerland JA; Majesky M; Arcot SS
Am J Physiol; 1996 Aug; 271(2 Pt 1):L208-15. PubMed ID: 8770058
[TBL] [Abstract][Full Text] [Related]
30. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
31. 4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.
Bai Y; Wang HM; Liu M; Wang Y; Lian GC; Zhang XH; Kang J; Wang HL
Int J Mol Med; 2014 Feb; 33(2):373-82. PubMed ID: 24337018
[TBL] [Abstract][Full Text] [Related]
32. The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats.
Bal E; Ilgin S; Atli O; Ergun B; Sirmagul B
Hum Exp Toxicol; 2013 Jul; 32(7):766-74. PubMed ID: 23821593
[TBL] [Abstract][Full Text] [Related]
33. Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.
Hironaka E; Hongo M; Sakai A; Mawatari E; Terasawa F; Okumura N; Yamazaki A; Ushiyama Y; Yazaki Y; Kinoshita O
Cardiovasc Res; 2003 Dec; 60(3):692-9. PubMed ID: 14659815
[TBL] [Abstract][Full Text] [Related]
34. Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
Kawai M; Zhang E; Kabwe JC; Okada A; Maruyama J; Sawada H; Maruyama K
BMC Pulm Med; 2022 Mar; 22(1):78. PubMed ID: 35247989
[TBL] [Abstract][Full Text] [Related]
35. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Yip HK
Circ J; 2008 May; 72(5):825-31. PubMed ID: 18441466
[TBL] [Abstract][Full Text] [Related]
36. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
38. Salvia Miltiorrhiza Bge.f.alba Ameliorates the Progression of Monocrotaline-Induced Pulmonary Hypertension by Protecting Endothelial Injury in Rats.
Wang Y; Cao SH; Cui YJ; Kong LK; Tian H; Cai HX; Wu YP; Han JJ; Zhao XM; Xia ZL
Tohoku J Exp Med; 2015 Jun; 236(2):155-62. PubMed ID: 26074502
[TBL] [Abstract][Full Text] [Related]
39. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB.
Bai Y; Li ZX; Wang HL; Lian GC; Wang Y
Int J Mol Med; 2017 Jul; 40(1):155-163. PubMed ID: 28560440
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
Broderick TL; King TM
Med Sci Monit; 2008 Dec; 14(12):BR261-4. PubMed ID: 19043358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
